Invivyd, Inc. - Common Stock, $0.0001 par value per share (IVVD)
CUSIP: 00534A102
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 291,486,949
- Total 13F shares
- 60,449,568
- Share change
- -9,976,661
- Total reported value
- $43,221,357
- Put/Call ratio
- 0%
- Price per share
- $0.72
- Number of holders
- 65
- Value change
- -$6,829,936
- Number of buys
- 28
- Number of sells
- 54
Quarterly Holders Quick Answers
What is CUSIP 00534A102?
CUSIP 00534A102 identifies IVVD - Invivyd, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00534A102:
Top shareholders of IVVD - Invivyd, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Adimab, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
21,687,906
|
$85,667,229 | — | 19 Jan 2024 | |
| MITHRIL II LP |
3/4/5
|
Other*, 10%+ Owner |
—
class O/S missing
|
11,241,580
|
$44,404,241 | — | 28 Mar 2022 | |
| Redmile Group, LLC |
3/4/5
13F
|
10%+ Owner · Company |
0.78%
from 13F
|
3,390,960
|
$13,394,292 | — | 10 Aug 2021 | |
| Rene Russo |
3/4/5
|
Director |
—
mixed-class rows
|
2,020,888
mixed-class rows
|
$7,841,915 | — | 05 Aug 2021 | |
| Mithril II GP LP |
13F
|
Company |
3.9%
|
11,241,580
|
$6,804,528 | — | 31 Mar 2025 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
3.8%
|
10,958,572
|
$6,633,224 | — | 31 Mar 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
3.3%
|
9,722,254
|
$5,884,880 | — | 31 Mar 2025 | |
| M28 Capital Management LP |
13F
|
Company |
3.2%
|
9,248,250
|
$5,597,966 | — | 31 Mar 2025 | |
| Ajay Royan |
3/4/5
|
Director |
—
mixed-class rows
|
11,249,799
mixed-class rows
|
$5,008,124 | — | 20 May 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
4.8%
|
5,775,549
|
$3,811,862 | $0 | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
1.8%
|
5,349,314
|
$3,237,940 | — | 31 Mar 2025 | |
| Cox Christopher T. |
3/4/5
|
Other* |
—
class O/S missing
|
679,822
|
$2,685,297 | — | 28 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.5%
|
4,396,990
|
$2,660,179 | — | 31 Mar 2025 | |
| Polaris Venture Partners V, L.P. |
3/4/5
|
Other* |
—
class O/S missing
|
497,660
|
$1,965,757 | — | 28 Mar 2022 | |
| 683 Capital Management, LLC |
13F
|
Company |
1%
|
3,000,000
|
$1,815,900 | — | 31 Mar 2025 | |
| Terrance McGuire |
3/4/5
|
Director |
—
mixed-class rows
|
3,116,757
mixed-class rows
|
$1,366,240 | — | 20 May 2025 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
0.62%
|
1,799,595
|
$1,089,295 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.56%
|
1,625,654
|
$984,114 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.34%
|
997,133
|
$603,565 | — | 31 Mar 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.32%
|
933,500
|
$565,048 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.25%
|
741,122
|
$448,601 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.22%
|
655,278
|
$399,720 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.2%
|
589,034
|
$356,542 | — | 31 Mar 2025 | |
| Duquesne Family Office LLC |
13F
|
Company |
0.2%
|
571,425
|
$346,000 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.15%
|
440,694
|
$266,620 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.14%
|
410,711
|
$248,603 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.14%
|
400,000
|
$242,120 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.09%
|
260,686
|
$157,793 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.09%
|
255,970
|
$154,939 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.08%
|
240,607
|
$145,639 | — | 31 Mar 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.07%
|
192,660
|
$117,000 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.06%
|
186,680
|
$112,997 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.06%
|
161,275
|
$97,620 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.04%
|
113,115
|
$68,469 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.04%
|
109,130
|
$66,056 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.04%
|
108,999
|
$65,978 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.04%
|
107,119
|
$64,839 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.03%
|
100,240
|
$60,675 | — | 31 Mar 2025 | |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC |
13F
|
Company |
0.03%
|
96,507
|
$58,869 | — | 31 Mar 2025 | |
| a16z Perennial Management, L.P. |
13F
|
Company |
0.03%
|
79,869
|
$48,345 | — | 31 Mar 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.03%
|
78,845
|
$48,000 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
79,133
|
$47,871 | — | 31 Mar 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.02%
|
71,213
|
$43,105 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.02%
|
64,570
|
$39,000 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
57,661
|
$34,903 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.02%
|
48,309
|
$29,241 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
47,852
|
$28,964 | — | 31 Mar 2025 | |
| Cerity Partners LLC |
13F
|
Company |
0.01%
|
39,293
|
$23,784 | — | 31 Mar 2025 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.01%
|
39,266
|
$23,768 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
39,237
|
$23,738 | — | 31 Mar 2025 |
Institutional Holders of Invivyd, Inc. - Common Stock, $0.0001 par value per share (IVVD) as of Q2 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.